发明名称 Therapeutic compositions
摘要 An oral composition, suitable as a hypoglycemic agent, includes an isolate from the leaves of Gymnema sylvestre, having a specified molecular weight. The isolate has a molecular weight at least about 3000 Daltons as determined by molecular weight cut-off filtration. Glucose metabolism in a human patient can be regulated by dosage forms that contain the aforesaid isolate from the leaves of Gymnema sylvestre, in combination with a non-metabolizable, water-swellable polysaccharide such as the exudate of Sterculia urens, and a water-soluble polysaccharide such as guar gum. Optionally, the present oral compositions can include a physiologically acceptable calcium source, a physiologically acceptable metal carbonate salt, a physiologically acceptable chromium salt, and/or a physiologically acceptable vanadium compound. In addition, antioxidants such as ascorbic acid, cholecalciferol, d-alpha-tocopherol, the carotenoids, lycopene, lutein, and the like, can be included as well. The present compositions are useful for amelioration of cholesterolemia, obesity, chronic complications of diabetes and prophylaxis for patients predisposed to the foregoing.
申请公布号 US2004151783(A1) 申请公布日期 2004.08.05
申请号 US20030378789 申请日期 2003.03.04
申请人 CHATTERJI ARUN K. 发明人 CHATTERJI ARUN K.
分类号 A23L1/30;A23L1/304;A23L2/38;A61K9/00;A61K31/555;A61K31/575;A61K31/715;A61K33/00;A61K33/10;A61K33/24;A61K36/00;A61K36/10;A61K36/185;A61K36/27;A61K36/48;A61K45/06;(IPC1-7):A61K35/78;A61K33/26 主分类号 A23L1/30
代理机构 代理人
主权项
地址